Expression of a stabilized mutated bcat in melanocytes, along with a mutated human NRAS oncogene, constitutively activating the MAPK pathway (Tyr::NRASQ61K/°; Tyr::bcat-mut/°) led to accelerated onset and increased the number of melanomas in a mouse model [77]. Here, NRAS is linked to melanoma.